Logo image
Pharmacological activation of Nr4a rescues age-associated memory decline
Journal article   Peer reviewed

Pharmacological activation of Nr4a rescues age-associated memory decline

Snehajyoti Chatterjee, Emily N Walsh, Amy L Yan, K. Peter Giese, Stephen Safe and Ted Abel
Neurobiology of aging, Vol.85, pp.140-144
01/2020
DOI: 10.1016/j.neurobiolaging.2019.10.001
PMID: 31732218
url
https://www.ncbi.nlm.nih.gov/pmc/articles/6917472View
Open Access

Abstract

Age-associated cognitive impairments affect an individual's quality of life and are a growing problem in society. Therefore, therapeutic strategies to treat age-related cognitive decline are needed to enhance the quality of life among the elderly. Activation of the Nr4a family of transcription factors has been closely linked to memory formation and dysregulation of these transcription factors is thought to be associated with age-related cognitive decline. Previously, we have shown that Nr4a transcription can be activated by synthetic bisindole-derived compounds (C-DIM). C-DIM compounds enhance synaptic plasticity and long-term contextual fear memory in young healthy mice. In this study, we show that activation of Nr4a2 by 1,1-bis(3′-Indolyl)-1-(p-chlorophenyl) methane (C-DIM12), enhances long-term spatial memory in young mice and rescues memory deficits in aged mice. These findings suggest that C-DIM activators of Nr4a transcription may be suitable to prevent memory deficits associated with aging.\n•Pharmacological activation of Nr4a using C-DIM drugs enhances long-term memory in young mice.•C-DIM drug reverses long-term memory deficits in aged mice.•Nr4a could be a potential therapeutic target to treat age-related cognitive impairment.
Aging C-DIM drugs Nr4a Spatial memory

Details

Metrics

Logo image